Shelter Pharma Limited has submitted a regulatory disclosure under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the completion and dispatch of an export order.
The company has successfully completed the manufacturing and dispatch of an export purchase order received from Taha Drugs & Chemicals Co. Ltd for the supply of Foliman Tablets and Joemega Capsules. The order has been dispatched to Sudan.
Order Details (From Annexure 1):
- Name of Customer: Taha Drugs & Chemicals Co. Ltd
- Product: Nutraceutical Tablets & Capsules
- Order Value: USD 139,200
- Manufacturing Status: Completed
- Dispatch Status: Completed
- Value Dispatched till Date: USD 139,200
- Balance Value Pending Dispatch: NIL
- Nature of Order: Export Order
- Destination Country: Sudan
The company reports that its association with Taha Drugs & Chemicals Co. Ltd continues to yield encouraging results with steady repeat orders from Sudan, reflecting strong demand and growing market acceptance of its products. The company is also receiving exclusive orders from the Sudan market.
Manufacturing Quality:
All products are manufactured under Good Manufacturing Practices (GMP) certified by the FDA, in conjunction with adherence to applicable ISO standards.
Market Opportunity:
The company identifies a significant expansion opportunity in the nutraceutical products industry in the Sudan region, with the potential to earn approximately ₹50 crore from this market. This increased participation in the Sudan market provides a significant new opportunity for the company and supports its global expansion plans.